EE200200238A - Apolipoproteiin B-100 epitoobi mimeetpeptiidid, nende konkatemeer ja modifitseeritud peptiidid ningneid sisaldavad vaktsiinikompositsioonid - Google Patents
Apolipoproteiin B-100 epitoobi mimeetpeptiidid, nende konkatemeer ja modifitseeritud peptiidid ningneid sisaldavad vaktsiinikompositsioonidInfo
- Publication number
- EE200200238A EE200200238A EEP200200238A EEP200200238A EE200200238A EE 200200238 A EE200200238 A EE 200200238A EE P200200238 A EEP200200238 A EE P200200238A EE P200200238 A EEP200200238 A EE P200200238A EE 200200238 A EE200200238 A EE 200200238A
- Authority
- EE
- Estonia
- Prior art keywords
- peptides
- concatemer
- apolipoprotein
- epitope
- compositions containing
- Prior art date
Links
- 102000006991 Apolipoprotein B-100 Human genes 0.000 title 1
- 108010008150 Apolipoprotein B-100 Proteins 0.000 title 1
- 108091028732 Concatemer Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 108091005601 modified peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Child & Adolescent Psychology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20000052055 | 2000-09-04 | ||
| KR10-2001-0054005A KR100472841B1 (ko) | 2000-09-04 | 2001-09-04 | 아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물 |
| PCT/KR2001/001492 WO2002020040A1 (en) | 2000-09-04 | 2001-09-04 | Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200238A true EE200200238A (et) | 2003-06-16 |
Family
ID=26638363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200238A EE200200238A (et) | 2000-09-04 | 2001-09-04 | Apolipoproteiin B-100 epitoobi mimeetpeptiidid, nende konkatemeer ja modifitseeritud peptiidid ningneid sisaldavad vaktsiinikompositsioonid |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6825318B2 (et) |
| EP (1) | EP1315517B1 (et) |
| JP (1) | JP2004508029A (et) |
| CN (1) | CN1231262C (et) |
| AU (1) | AU8628601A (et) |
| BG (1) | BG106655A (et) |
| BR (1) | BR0107175A (et) |
| CA (1) | CA2389739A1 (et) |
| CZ (1) | CZ20021571A3 (et) |
| EE (1) | EE200200238A (et) |
| HU (1) | HUP0203251A2 (et) |
| IL (1) | IL149379A0 (et) |
| LT (1) | LT4989B (et) |
| MX (1) | MXPA02004505A (et) |
| NO (1) | NO20022147L (et) |
| RU (1) | RU2313536C2 (et) |
| SK (1) | SK6312002A3 (et) |
| WO (1) | WO2002020040A1 (et) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2527361A1 (en) * | 2003-06-11 | 2004-12-23 | Schering Aktiengesellschaft | Novel modified corin molecules having substitute activation sequences and uses thereof |
| KR100639397B1 (ko) * | 2004-03-18 | 2006-10-26 | (주)에스제이바이오메드 | 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물 |
| US20070054298A1 (en) * | 2005-08-12 | 2007-03-08 | Kent Kirshenbaum | Methods for enzyme-mediated coupling of oligomers |
| WO2007075335A2 (en) * | 2005-12-16 | 2007-07-05 | The Regents Of The University Of California | Modulation of in utero immune programming |
| US8961982B2 (en) * | 2005-12-16 | 2015-02-24 | The Regents Of The University Of California | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
| EP2076544A4 (en) * | 2006-09-25 | 2009-11-11 | Sj Biomed Inc | ANTI-OBESITY IMMONOGENIC HYBRID POLYPEPTIDES AND ANTI-OBESITY VACCINE COMPOSITION COMPRISING THE SAME |
| CN103520713B (zh) * | 2013-10-16 | 2015-10-28 | 西北农林科技大学 | 一种ApoB100酵母重组疫苗及其制备方法和应用 |
| US10434141B2 (en) | 2016-05-31 | 2019-10-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL131655A0 (en) * | 1997-03-04 | 2001-01-28 | Bio Technology General Corp | Isolation of tissue specific ligands and their use for targeting pharmaceuticals to organs |
| AU2801299A (en) * | 1998-03-04 | 1999-09-20 | Bio-Technology General Corporation | Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| CN1418106A (zh) * | 2000-03-03 | 2003-05-14 | 史密丝克莱恩比彻姆生物有限公司 | 疫苗 |
-
2001
- 2001-09-04 RU RU2003109439/13A patent/RU2313536C2/ru not_active IP Right Cessation
- 2001-09-04 CN CNB018030572A patent/CN1231262C/zh not_active Expired - Fee Related
- 2001-09-04 BR BR0107175-0A patent/BR0107175A/pt not_active Application Discontinuation
- 2001-09-04 EE EEP200200238A patent/EE200200238A/et unknown
- 2001-09-04 HU HU0203251A patent/HUP0203251A2/hu unknown
- 2001-09-04 CZ CZ20021571A patent/CZ20021571A3/cs unknown
- 2001-09-04 AU AU86286/01A patent/AU8628601A/en not_active Abandoned
- 2001-09-04 WO PCT/KR2001/001492 patent/WO2002020040A1/en not_active Application Discontinuation
- 2001-09-04 SK SK631-2002A patent/SK6312002A3/sk unknown
- 2001-09-04 CA CA002389739A patent/CA2389739A1/en not_active Abandoned
- 2001-09-04 MX MXPA02004505A patent/MXPA02004505A/es unknown
- 2001-09-04 EP EP01965715A patent/EP1315517B1/en not_active Expired - Lifetime
- 2001-09-04 JP JP2002524523A patent/JP2004508029A/ja active Pending
- 2001-09-04 IL IL14937901A patent/IL149379A0/xx unknown
-
2002
- 2002-04-25 BG BG106655A patent/BG106655A/bg unknown
- 2002-04-29 LT LT2002051A patent/LT4989B/lt not_active IP Right Cessation
- 2002-05-03 NO NO20022147A patent/NO20022147L/no not_active Application Discontinuation
-
2003
- 2003-03-04 US US10/378,707 patent/US6825318B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL149379A0 (en) | 2002-11-10 |
| WO2002020040A1 (en) | 2002-03-14 |
| JP2004508029A (ja) | 2004-03-18 |
| AU8628601A (en) | 2002-03-22 |
| BR0107175A (pt) | 2002-07-02 |
| EP1315517B1 (en) | 2010-10-20 |
| HUP0203251A2 (hu) | 2003-01-28 |
| LT4989B (lt) | 2003-01-27 |
| CA2389739A1 (en) | 2002-03-14 |
| RU2003109439A (ru) | 2004-07-20 |
| US6825318B2 (en) | 2004-11-30 |
| BG106655A (bg) | 2004-08-31 |
| EP1315517A4 (en) | 2005-02-09 |
| MXPA02004505A (es) | 2004-09-10 |
| CN1392798A (zh) | 2003-01-22 |
| LT2002051A (en) | 2002-09-25 |
| RU2313536C2 (ru) | 2007-12-27 |
| SK6312002A3 (en) | 2002-09-10 |
| EP1315517A1 (en) | 2003-06-04 |
| NO20022147D0 (no) | 2002-05-03 |
| CN1231262C (zh) | 2005-12-14 |
| NO20022147L (no) | 2002-05-03 |
| CZ20021571A3 (cs) | 2002-09-11 |
| US20030211997A1 (en) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1179014T3 (da) | Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII | |
| CY2011020I2 (el) | Νεα πεπτιδια ως αναστολεα πρωτεασης ns3-σερινης του ιου ηπατιτιδας c | |
| IL155842A0 (en) | Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus | |
| PT981375E (pt) | Composicoes farmaceuticas contendo proteinas do plasma | |
| DE69941116D1 (de) | G von gdf-8 | |
| DK1042359T3 (da) | k-Opioidreceptorpeptider | |
| CY1106156T1 (el) | Νεα χρηση βουδεσονιδης και φορμοτepολης | |
| DE60217126D1 (de) | Herstellung von aminopyrimidinverbindungen | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| DE60126814D1 (de) | Inhalation von stickoxid | |
| DE60129572D1 (de) | Verwendung von antikörpern gegen spezifische mhc-peptidkomplexe | |
| EE200200238A (et) | Apolipoproteiin B-100 epitoobi mimeetpeptiidid, nende konkatemeer ja modifitseeritud peptiidid ningneid sisaldavad vaktsiinikompositsioonid | |
| DE60019960D1 (de) | Herstellung von isobutencopolymere | |
| NO20042173L (no) | Fremgangsmate for fremstilling av rekombinant polypeptid | |
| NO20030239D0 (no) | Modifisert virus | |
| ATE332960T1 (de) | Stabilisierung von getränken | |
| IT1324894B (it) | Miscele di stabilizzanti | |
| DE60142051D1 (de) | Herstellung von perfluorolefinen | |
| ATE369137T1 (de) | Lyophilisierte formulierung enthaltend olanzapin | |
| DE60133273D1 (de) | Inhibitoren von peptid deformylase | |
| HUP0400737A3 (en) | Use of l-carnitine for preparation of compositions for stabilizing the proteins | |
| DE69930733D1 (de) | Herstellung von substituierten (amino)alkoxysilanen | |
| DE60112280D1 (de) | Inhibitoren von peptid deformylase | |
| IS5829A (is) | Peptíðbrot úr kólerutoxíni B eða iðratoxíni B semhjálparefni í bóluefni | |
| DE60224280D1 (de) | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis |